Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atorvastatin for spontaneous subarachnoid hemorrhage
ChiCTR-IPR-14005395Phase 4Recruiting
- Sponsor
- Chinese PLA General Hospital
- Start
- Oct 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of atorvastatin in subarachnoid hemorrhage (SAH) (2 arms), sponsored by Chinese PLA General Hospital. Primary endpoints: GOS score, vasospasm and 1 more. Started Oct 2014; status: recruiting.
02
Drugs
atorvastatin
03
Conditions
subarachnoid hemorrhage (SAH)
Beyond the preview
Go deeper on ChiCTR-IPR-14005395.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-14005395.